Back
Bristol-Myers Squibb Vs. Gilead Sciences Industry Stock Comparison
Sell
38
BMY
Bristol-Myers Squibb
Last Price:
44.93
Seasonality Move:
0.31%
Sell
26
GILD
Gilead Sciences
Last Price:
65.98
Seasonality Move:
4.15%
Sell
38
Bristol-Myers Squibb (BMY)
is a Sell
Is Bristol-Myers Squibb a Buy, Sell or Hold?
- The current Bristol-Myers Squibb [BMY] share price is $44.74. The Score for BMY is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- BMY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
Gilead Sciences (GILD)
is a Sell
Is Gilead Sciences a Buy, Sell or Hold?
- The current Gilead Sciences [GILD] share price is $64.60. The Score for GILD is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- GILD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BMY Stock Price Chart
What is Bristol-Myers Squibb's stock price today?
-
The Bristol-Myers Squibb share price today is $44.74
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMY is experiencing buying pressure, which is a positive indicator for future bullish movement.
GILD Stock Price Chart
What is Gilead Sciences's stock price today?
-
The Gilead Sciences share price today is $64.60
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GILD is experiencing selling pressure, which indicates risk of future bearish movement.
BMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.76 | Sell |
| Relative Strength Index (14 RSI): | 35.65 | Sell |
| Chaikin Money Flow: | 9487664 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.38 - 49.78) | Sell |
| Bollinger Bands (100): | (47.54 - 52.62) | Sell |
GILD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.46 | Sell |
| Relative Strength Index (14 RSI): | 30.67 | Sell |
| Chaikin Money Flow: | -3545147 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (65.16 - 68.26) | Sell |
| Bollinger Bands (100): | (68.34 - 80.52) | Sell |
BMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.02 | Buy |
| 20-day SMA: | 46.17 | Sell |
| 50-day SMA: | 49.77 | Sell |
| 200-day SMA: | 53.25 | Sell |
| 8-day EMA: | 44.46 | Buy |
| 20-day EMA: | 46.06 | Sell |
| 50-day EMA: | 48.35 | Sell |
| 200-day EMA: | 53.52 | Sell |
GILD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 65.16 | Sell |
| 20-day SMA: | 66.1 | Sell |
| 50-day SMA: | 69.92 | Sell |
| 200-day SMA: | 75.78 | Sell |
| 8-day EMA: | 65.23 | Sell |
| 20-day EMA: | 66.39 | Sell |
| 50-day EMA: | 69.3 | Sell |
| 200-day EMA: | 74.53 | Sell |
Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, an increase next quarter of $0.22 per share, a decrease this year of $6.86 per share, and an increase next year of $6.41 per share.
Gilead Sciences Earnings Growth & GILD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.01 per share, and an increase next year of $3.44 per share.
Bristol-Myers Squibb Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Gilead Sciences Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||